33 research outputs found

    Ž . Vasopressin in the forebrain of common marmosets Callithrix jacchus : studies with in situ hybridization, immunocytochemistry and receptor autoradiography

    Get PDF
    Abstract Ž . The distribution of vasopressin AVP producing cells, their projections and AVP receptors was examined in the brain of common Ž . marmosets Callithrix jacchus using in situ hybridization, immunocytochemistry and receptor autoradiography. Clusters of cells labeled Ž . Ž . Ž . for AVP mRNA or stained for AVP immunoreactivity AVP-ir were found in the paraventricular PVN , supraoptic SON and Ž . suprachiasmatic nuclei SCN of the hypothalamus. Scattered AVP producing cells were also found in the lateral hypothalamus and the Ž . bed nucleus of the stria terminalis BST . Neither AVP mRNA-labeled nor AVP-ir cells were detected in the amygdala. Although AVP-ir fibers were evident outside of the hypothalamic-neurohypophyseal tract, a plexus of fibers in the lateral septum, as observed in the rat brain, was not detected. Receptor autoradiography using 125 I-linear-AVP revealed specific binding for AVP receptors in the nucleus accumbens, diagonal band, lateral septum, the BST, SCN, PVN, amygdala, anterodorsal and ventromedial nucleus of the hypothalamus, indicating sites for central AVP action in the marmoset brain. Together, these data provide a comprehensive picture of AVP pathways in the marmoset brain, demonstrating differences from rodents in the distribution of cell bodies, fibers and receptors. q 1997 Elsevier Science B.V

    Cognitive Aging and Self-Management: Opportunities for Technology

    No full text
    Presented on January 16, 2019 at 3:00 p.m. in the J. S. Coon Building, Room 250.Kathleen C. Insel is the Interim Chair and Professor of Nursing in the College of Nursing at the University of Arizona. The focus of her research is on cognitive function over the lifespan and implications of cognitive function (specifically executive function and working memory) on self-management of chronic disease, or in the case of children, on school achievement.Runtime: 68:13 minutesSelf-management of chronic conditions increases among older adults at the same time capacity for self-management may diminish. Addressing limitations in prospective memory through strategies developed to improve medication adherence, provides an exemplar for applying what is known about cognitive aging to support older adults leading to optimal aging and improved quality of life. Leveraging technology, the use of which is ever more ubiquitous in this population, can provide a means for general dissemination of these strategies

    Chemotherapy-Related Change in Cognitive Function: A Conceptual Model

    No full text

    Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition.

    No full text
    The signaling molecule cAMP primarily mediates its effects by activating PKA and/or exchange protein activated by cAMP (Epac). Epac has been implicated in many responses in cells, but its precise roles have been difficult to define in the absence of Epac inhibitors. Epac, a guanine nucleotide exchange factor for the low molecular weight G protein Rap, is directly activated by cAMP. Using a bioluminescence resonance energy transfer-based assay (CAMYEL) to examine modulators of Epac activity, we took advantage of its intramolecular movement that occurs upon cAMP binding to assess Epac activation. We found that the use of CAMYEL can detect the binding of cAMP analogs to Epac and their modulation of its activity and can distinguish between agonists (cAMP), partial agonists (8-chlorophenylthio-cAMP), and super agonists (8-chlorophenylthio-2'-O-Me-cAMP). The CAMYEL assay can also identify competitive and uncompetitive Epac inhibitors, e.g. (Rp)-cAMPS and CE3F4, respectively. To confirm the results with the CAMYEL assay, we used Swiss 3T3 cells and assessed the ability of cyclic nucleotide analogs to modulate the activity of Epac or PKA, determined by Rap1 activity or VASP phosphorylation, respectively. We used computational molecular modeling to analyze the interaction of analogs with Epac1. The results reveal a rapid means to identify modulators (potentially including allosteric inhibitors) of Epac activity that also provides insight into the mechanisms of Epac activation and inhibition

    Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.

    No full text
    Epac, a guanine nucleotide exchange factor for the low molecular weight G protein Rap, is an effector of cAMP signaling and has been implicated to have roles in numerous diseases, including diabetes mellitus, heart failure, and cancer. We used a computational molecular modeling approach to predict potential binding sites for allosteric modulators of Epac and to identify molecules that might bind to these regions. This approach revealed that the conserved hinge region of the cyclic nucleotide-binding domain of Epac1 is a potentially druggable region of the protein. Using a bioluminescence resonance energy transfer-based assay (CAMYEL, cAMP sensor using YFP-Epac-Rluc), we assessed the predicted compounds for their ability to bind Epac and modulate its activity. We identified a thiobarbituric acid derivative, 5376753, that allosterically inhibits Epac activity and used Swiss 3T3 and HEK293 cells to test the ability of this compound to modulate the activity of Epac and PKA, as determined by Rap1 activity and vasodilator-stimulated phosphoprotein phosphorylation, respectively. Compound 5376753 selectively inhibited Epac in biochemical and cell migration studies. These results document the utility of a computational approach to identify a domain for allosteric regulation of Epac and a novel compound that prevents the activation of Epac1 by cAMP
    corecore